These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 10878552

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
    Uekita T, Yamanouchi K, Sato H, Tojo H, Seiki M, Tachi C.
    Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y.
    Cancer Res; 1997 May 15; 57(10):2055-60. PubMed ID: 9158005
    [Abstract] [Full Text] [Related]

  • 6. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
    Ottino P, He J, Axelrad TW, Bazan HE.
    Invest Ophthalmol Vis Sci; 2005 Feb 15; 46(2):487-96. PubMed ID: 15671273
    [Abstract] [Full Text] [Related]

  • 7. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
    Jo M, Thomas LE, Wheeler SE, Curry TE.
    Biol Reprod; 2004 Apr 15; 70(4):1024-32. PubMed ID: 14668206
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
    Imanishi Y, Fujii M, Tokumaru Y, Tomita T, Kanke M, Kanzaki J, Kameyama K, Otani Y, Sato H.
    Hum Pathol; 2000 Aug 15; 31(8):895-904. PubMed ID: 10987249
    [Abstract] [Full Text] [Related]

  • 11. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct 15; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

  • 12. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S, Moore BA, Alexander-Lister LD, Hallit SL, Windsor LJ, Engler JA.
    Cancer Res; 2001 Aug 15; 61(16):6264-75. PubMed ID: 11507081
    [Abstract] [Full Text] [Related]

  • 13. Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats.
    Kovalenko P, Fujinaka H, Yoshida Y, Kawamura H, Qu Z, El-Shemi AG, Li H, Matsuki A, Bilim V, Yaoita E, Abo T, Uchiyama M, Yamamoto T.
    Int Immunol; 2004 May 15; 16(5):625-34. PubMed ID: 15096492
    [Abstract] [Full Text] [Related]

  • 14. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
    Tomita M, Koike H, Han GD, Shimizu F, Kawachi H.
    Clin Exp Nephrol; 2004 Mar 15; 8(1):17-26. PubMed ID: 15067512
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
    Sanders JS, van Goor H, Hanemaaijer R, Kallenberg CG, Stegeman CA.
    Nephrol Dial Transplant; 2004 Jun 15; 19(6):1412-9. PubMed ID: 15034162
    [Abstract] [Full Text] [Related]

  • 17. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
    Isome M, Fujinaka H, Adhikary LP, Kovalenko P, El-Shemi AG, Yoshida Y, Yaoita E, Takeishi T, Takeya M, Naito M, Suzuki H, Yamamoto T.
    Nephrol Dial Transplant; 2004 Dec 15; 19(12):2997-3004. PubMed ID: 15574997
    [Abstract] [Full Text] [Related]

  • 18. Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis.
    Zhou X, Hovell CJ, Pawley S, Hutchings MI, Arthur MJ, Iredale JP, Benyon RC.
    Liver Int; 2004 Oct 15; 24(5):492-501. PubMed ID: 15482348
    [Abstract] [Full Text] [Related]

  • 19. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N.
    Lab Invest; 1996 May 15; 74(5):941-51. PubMed ID: 8642789
    [Abstract] [Full Text] [Related]

  • 20. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
    Nakada M, Miyamori H, Yamashita J, Sato H.
    Cancer Res; 2003 Jun 15; 63(12):3364-9. PubMed ID: 12810672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.